tipifarnib has been researched along with ethyl 1-benzyl-3-hydroxy-2(5h)-oxopyrrole-4-carboxylate in 1 studies
| Studies (tipifarnib) | Trials (tipifarnib) | Recent Studies (post-2010) (tipifarnib) | Studies (ethyl 1-benzyl-3-hydroxy-2(5h)-oxopyrrole-4-carboxylate) | Trials (ethyl 1-benzyl-3-hydroxy-2(5h)-oxopyrrole-4-carboxylate) | Recent Studies (post-2010) (ethyl 1-benzyl-3-hydroxy-2(5h)-oxopyrrole-4-carboxylate) |
|---|---|---|---|---|---|
| 309 | 92 | 94 | 21 | 0 | 12 |
| Protein | Taxonomy | tipifarnib (IC50) | ethyl 1-benzyl-3-hydroxy-2(5h)-oxopyrrole-4-carboxylate (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.0317 | |
| Aldo-keto reductase family 1 member B1 | Homo sapiens (human) | 0.26 | |
| Aldo-keto reductase family 1 member A1 | Sus scrofa (pig) | 1.8252 | |
| Aldo-keto reductase family 1 member A1 | Rattus norvegicus (Norway rat) | 0.028 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for tipifarnib and ethyl 1-benzyl-3-hydroxy-2(5h)-oxopyrrole-4-carboxylate
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |